Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Age-Related Time-to-Onset Analysis of Drug-Associated Erythema Multiforme Using the Japanese Adverse Drug Event Report Database.

Created on 06 Sep 2026

Authors

Hideyuki Tanaka, Satoshi Nakao, Kana Sugishita, Tomofumi Yamazaki, Seiichiro Ito, Koichi Kageyama, Mugita Sato, Yoko Ino, Kazuhiro Iguchi, Mitsuhiro Nakamura

Published in

Cureus. Volume 18. Issue 8. Pages e114044. Epub Aug 06, 2026.

Abstract

Erythema multiforme (EM) is a rare immune-mediated skin condition often triggered by infections, drugs, or autoimmune diseases. Age-related differences in drug exposure, comorbidities, and biological factors may affect adverse event reporting patterns; however, age-related patterns in EM onset remain unclear. This study investigated age-related patterns in reported time-to-onset of EM.
The observation period was defined as 1-180 days from the initiation of drug administration. Kendall's tau-b rank correlation analysis was used to evaluate the association between ordered age categories and reported time to onset. The Kaplan-Meier method with a log-rank test was used to compare EM onset profiles between two age groups (<60 and ≥60 years).
A positive association was observed between age category and reported time-to-onset (Kendall's tau-b = 0.188, p < 0.001). The median time-to-onset was 10.0 days in both men and women, although the Kaplan-Meier curves differed significantly by sex (log-rank p = 0.012). The median time-to-onset was 8.0 (3.0-13.0) days for those aged <60 years and 12.0 (7.0-24.5) days for those aged ≥60 years (log-rank p < 0.001).
Older age was associated with longer reported time-to-onset of EM, suggesting age-related differences in reported EM onset patterns in a spontaneous reporting database.

PMID:
42701639
Bibliographic data and abstract were imported from PubMed on 06 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement